{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:31:12Z","timestamp":1761895872360},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,6,21]],"date-time":"2014-06-21T00:00:00Z","timestamp":1403308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00277-014-2138-5","type":"journal-article","created":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T09:08:44Z","timestamp":1403255324000},"page":"1903-1911","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy"],"prefix":"10.1007","volume":"93","author":[{"given":"Manal A.","family":"Salah-Eldin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"El-Sadda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,21]]},"reference":[{"issue":"3","key":"2138_CR1","first-page":"1S","volume":"26","author":"J Hoofnagle El","year":"1997","unstructured":"El Hoofnagle J, Tralka TS (1997) Introduction: The National Institutes of Health Consensus Development Conference: management of hepatitis C virus. Hepatology 26(3):1S\u20132S, supplement","journal-title":"Hepatology"},{"issue":"3","key":"2138_CR2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0168-8278(92)90073-X","volume":"15","author":"AL Zignego","year":"1992","unstructured":"Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Br\u00e9chot C (1992) Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 15(3):382\u2013386","journal-title":"J Hepatol"},{"issue":"1","key":"2138_CR3","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S1590-8658(07)80009-0","volume":"39","author":"AL Zignego","year":"2007","unstructured":"Zignego AL, Giannini C, Monti M, Gragnani L (2007) Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis 39(1):S38\u2013S45","journal-title":"Dig Liver Dis"},{"issue":"2","key":"2138_CR4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2141.1994.tb05036.x","volume":"88","author":"C Ferri","year":"1994","unstructured":"Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A et al (1994) Hepatitis C virus infection in patients with non-Hodgkin\u2019s lymphoma. Br J Haematol 88(2):392\u2013394","journal-title":"Br J Haematol"},{"issue":"10","key":"2138_CR5","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood.V87.10.4296.bloodjournal87104296","volume":"87","author":"F Silvestri","year":"1996","unstructured":"Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, Falasca E, Botta GA, Baccarani M (1996) Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 87(10):4296\u20134301","journal-title":"Blood"},{"issue":"6","key":"2138_CR6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-127-6-199709150-00002","volume":"127","author":"E Zuckerman","year":"1997","unstructured":"Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M et al (1997) Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 127(6):423\u2013428","journal-title":"Ann Intern Med"},{"key":"2138_CR7","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","volume":"15","author":"L Dal Maso","year":"2006","unstructured":"Dal Maso L, Franceschi S (2006) Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 15:2078\u20132085","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2138_CR8","first-page":"508","volume":"109","author":"R Rai","year":"2000","unstructured":"Rai R, Weiss LM (2000) Hepatitis V virus and non-Hodgkin\u2019s lymphoma. Am J Clin Pathol 109:508\u2013509","journal-title":"Am J Clin Pathol"},{"key":"2138_CR9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"P TIN-HsLPF","year":"1993","unstructured":"TIN-HsLPF P (1993) a predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N Engl J Med 329:987\u2013994","journal-title":"N Engl J Med"},{"issue":"4","key":"2138_CR10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235\u2013242","journal-title":"N Engl J Med"},{"issue":"5","key":"2138_CR11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","volume":"7","author":"M Pfreundschuh","year":"2006","unstructured":"Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K, Ma D, Gill D et al (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 7(5):379\u2013391","journal-title":"Lancet Oncol"},{"key":"2138_CR12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3324\/haematol.2009.005819","volume":"94","author":"PD Ziakas","year":"2009","unstructured":"Ziakas PD, Karsaliakos P, Mylonakis E (2009) Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance. Haematologica 94:998\u20131005","journal-title":"Haematologica"},{"key":"2138_CR13","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1224::AID-CNCR23>3.0.CO;2-6","volume":"83","author":"E Zuckerman","year":"1998","unstructured":"Zuckerman E, Zuckerman T, Douer D, Qian D, Levine AM et al (1998) Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer 83:1224\u20131230","journal-title":"Cancer"},{"issue":"9","key":"2138_CR14","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/annonc\/mdl131","volume":"17","author":"C Visco","year":"2006","unstructured":"Visco C, Arcaini L, Brusamolino E, Burcheri S, Ambrosetti A, Merli M, Bonoldi E et al (2006) Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy. Ann Oncol 17(9):1434\u20131440","journal-title":"Ann Oncol"},{"issue":"6","key":"2138_CR15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","volume":"24","author":"C Besson","year":"2006","unstructured":"Besson C, Canioni D, Lepage E, Pol S, Morel P, Lederlin P, Van Hoof A et al (2006) Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d\u2019Etude des Lymphomes de l\u2019Adulte programs. J Clin Oncol 24(6):953\u2013960","journal-title":"J Clin Oncol"},{"key":"2138_CR16","unstructured":"El-Zanaty F, Way A (2009) Egypt Demographic and Health Survey 2008. Egyptian: Ministry of Health. Cairo: El-Zanaty and Associates, and Macro International"},{"issue":"12","key":"2138_CR17","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17(12):3835\u20133849","journal-title":"J Clin Oncol"},{"key":"2138_CR18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1600-0609.2008.01039.x","volume":"80","author":"O Dizdar","year":"2008","unstructured":"Dizdar O, Tapan U, Aksoy S, Harputluoglu H, Saadettin Kilickap S, Barista I et al (2008) Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C. Eur J Haematol 80:381\u2013385","journal-title":"Eur J Haematol"},{"issue":"3","key":"2138_CR19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3324\/haematol.2013.094318","volume":"99","author":"M Merli","year":"2014","unstructured":"Merli M, Visco C, Spina M, Luminari S, Ferretti V, Gotti M, Rattotti S, Fiaccadori V, Rusconi C, Targhetta C, Stelitano C, Levis A, Ambrosetti A, Rossi D, Rigacci L, D\u2019Arco A, Musto P, Chiappella A, Baldini L, Bonfichi M, Arcaini L (2014) Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi. Haematologica 99(3):489\u2013496","journal-title":"Haematologica"},{"issue":"24","key":"2138_CR20","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1182\/blood-2010-06-289231","volume":"116","author":"D Ennishi","year":"2010","unstructured":"Ennishi D, Maeda Y, Niitsu N, Kojima M, Izutsu K, Takizawa J et al (2010) Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis. Blood 116(24):5119\u20135125","journal-title":"Blood"},{"key":"2138_CR21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-0609.2004.00376.x","volume":"74","author":"S Takai","year":"2005","unstructured":"Takai S, Tsurumi H, Ando K, Kasahara S, Sawada M, Yamada T, Hara T et al (2005) Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol 74:158\u2013165","journal-title":"Eur J Haematol"},{"key":"2138_CR22","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","volume":"101","author":"F Zaja","year":"2003","unstructured":"Zaja F, De Vita S, Mazzaro C, Sacco S, Damiani D, De Marchi G, Michelutti A et al (2003) Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101:3827\u20133834","journal-title":"Blood"},{"key":"2138_CR23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1182\/blood-2006-08-041525","volume":"109","author":"G Lake-Bakaar","year":"2007","unstructured":"Lake-Bakaar G, Dustin L, McKeating J, Newton K, Freeman V, Frost SD (2007) Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease. Blood 109:845\u2013846","journal-title":"Blood"},{"key":"2138_CR24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ajh.21564","volume":"85","author":"L Arcaini","year":"2010","unstructured":"Arcaini L, Merli M, Passamonti F, Bruno R, Brusamolino E, Sacchi P, Rattotti S, Orlandi E, Rumi E, Ferretti V, Rizzi S, Meli E, Pascutto C, Paulli M, Lazzarino M (2010) Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin\u2019s lymphomas. Am J Hematol 85:46\u201350","journal-title":"Am J Hematol"},{"key":"2138_CR25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.dld.2010.05.010","volume":"43","author":"M Marignani","year":"2011","unstructured":"Marignani M, Mangone M, Cox MC, Angeletti S, Veggia B, Ferrari A, di Fonzo M, Begini P, Gigante E, Laverde G, Aloe- Spiriti A, Monarca B, Delle Fave G (2011) HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin\u2019s lymphoma treated with rituximab-containing regimens. Dig Liver Dis 43:139\u2013142","journal-title":"Dig Liver Dis"},{"key":"2138_CR26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajh.21022","volume":"83","author":"D Ennishi","year":"2008","unstructured":"Ennishi D, Terui Y, Yokoyama M, Mishima Y, Takahashi S, Takeuchi K, Okamoto H, Tanimoto M, Hatake K (2008) Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy. Am J Hematol 83:59\u201362","journal-title":"Am J Hematol"},{"key":"2138_CR27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3892\/or.2012.1883","volume":"28","author":"H Nishikawa","year":"2012","unstructured":"Nishikawa H, Tsudo M, Osaki Y (2012) Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: a single center experience. Oncol Rep 28:835\u2013840","journal-title":"Oncol Rep"},{"key":"2138_CR28","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","volume":"23","author":"LH Sehn","year":"2005","unstructured":"Sehn LH, Donaldson J, Chhanabhai M, Fitzgerald C, Gill K, Klasa R, MacPherson N et al (2005) Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 23:5027\u20135033","journal-title":"J Clin Oncol"},{"key":"2138_CR29","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","volume":"24","author":"TM Habermann","year":"2006","unstructured":"Habermann TM, Weller EA, Morrison VA, Gascoyne RD, Cassileth PA, Cohn JB, Dakhil SR, Woda B, Fisher RI, Peterson BA, Horning SJ (2006) Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 24:3121\u20133127","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2138-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2138-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2138-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T22:36:07Z","timestamp":1716849367000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2138-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,21]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["2138"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2138-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,21]]}}}